MAIN LICENSE AND REGISTRY CONTENTS INDEX CONTACT

MONOCLONAL ANTIBODY INDEX. Cancer -- 2012 update.

MOAB DATA TABLE (Ordered by MOAB NAME).

OUR ID MOAB NAME RELATED MOAB SPECIES IG TYPE MOAB/CELL LINE CHARACTERISTICS TARGET CELL/TISSUE TARGET CANCER(*) AG/EPITOPE NAME AG Mw/kDa (ip) AG/EPITOPE CHARACTERISTICS STUDY PHASE(**) PATENT ASSIGNEE/PRODUCER/DEVELOPER/DISTRIBUTOR (other names of the moab, antigen or derivatives)
1351 Lym-1 IL-2 fusion proteins, chimeric (IgG1) and scFv variants, radiolabeled derivatives m G2a Ka= 4.02x10(8) M(-1) / bsc= 1.1x10(6) B lymphocytes lymphoma (NHL), leukemia - 31-35 light chain of polymorphic HLA-DR10 (class II) protein II-III Southern California Univ., US / Northwestern Univ., US / Techniclone, US (Oncolym) / Schering, Germany / Peregrine Pharm., US / Berlex Labs., US

BIBLIOGRAPHY